Lv1
30 积分 2024-08-07 加入
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
1天前
已完结
Emerging targeted therapies in non-small cell lung cancer 10.1586/14737140.2016.1126514
1天前
已关闭
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis
7个月前
已完结
皖公网安备34019202002308
